<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-marinedrugs-17-00374" class="ref">
 <label class="label">30.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Kromhout</surname>
    <given-names class="given-names">D.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Giltay</surname>
    <given-names class="given-names">E.J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Geleijnse</surname>
    <given-names class="given-names">J.M.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Alpha Omega Trial</surname>
    <given-names class="given-names">G.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">n-3 fatty acids and cardiovascular events after myocardial infarction</article-title>
  <source class="source">N. Engl. J. Med.</source>
  <year class="year">2010</year>
  <volume class="volume">363</volume>
  <fpage class="fpage">2015</fpage>
  <lpage class="lpage">2026</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1056/NEJMoa1003603</pub-id>
  <pub-id pub-id-type="pmid" class="pub-id">20929341</pub-id>
 </element-citation>
</ref>
